Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutranomy is a health technology company that leverages circadian biology to provide personalized nutrition and lifestyle recommendations. Founded by leading researchers from the Salk Institute, the company's platform analyzes individual biological data to optimize the timing of food intake, sleep, and activity. Their core mission is to improve metabolic health and enhance longevity through time-restricted feeding and data-driven insights. The company translates complex scientific findings into actionable tools for consumers, aiming to prevent and manage chronic conditions like obesity and type 2 diabetes. Nutranomy represents a shift toward chrononutrition as a primary pillar of preventive healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutranomy.